GAM
IPXL

Gotham Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Gotham Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-733,848
Closed -$21.1M – 1113
2016
Q2 		$21.1M Buy
733,848
+255,228
+53% +$8.32M 0.25% 116
2016
Q1 		$15.3M Buy
478,620
+458,819
+2,317% +$16.1M 0.17% 201
2015
Q4 		$847K Buy
+19,801
New +$791K 0.01% 623
2015
Q1 		– Sell
-79,609
Closed -$2.52M – 1076
2014
Q4 		$2.52M Buy
79,609
+45,900
+136% +$1.34M 0.02% 493
2014
Q3 		$799K Buy
+33,709
New +$864K 0.01% 664

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Gotham Asset Management's IPXL Position: Q3 2016 in Review

Gotham Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q3 2016, closing a stake of 733,848 shares — an estimated $21.1M sold.

Gotham Asset Management first reported a position in IPXL in Q3 2014 and held it in 5 quarters. The position peaked at $21.1M in Q2 2016. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

  • Gotham Asset Management reported no remaining Impax Laboratories, Inc. position as of Q3 2016 after selling out during the quarter.
  • Gotham Asset Management sold 733,848 Impax Laboratories, Inc. shares in Q3 2016, an estimated $21.1M.
  • Gotham Asset Management first reported a position in Impax Laboratories, Inc. in Q3 2014 and held it in 5 quarters.
  • Gotham Asset Management's Impax Laboratories, Inc. position peaked at $21.1M in Q2 2016.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Gotham Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.